Dianosic
France - StrasbourgBiotechnology
Focus: Dianosic is a French biotech company developing an intranasal balloon device for epistaxis (nosebleeds), representing a novel medical device approach to a common clinical problem. Founded in 2020 and based in Strasbourg, the company operates at early stage with minimal public disclosure.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Dianosic
AI assessmentNot HiringNo open roles listed right now. Follow Dianosic to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Asymmetric Balloon
Pre-Commercial
Single pipeline asset with no commercialization or revenue data; device approach differentiates from systemic therapies but lacks clinical validation beyond 1 trial.
Pipeline & Clinical Trials
asymmetric balloon
EpistaxisHelp build intelligence for Dianosic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.